What does BDQ do
Reading File
Finding Sources
Searching PubMed
bedaquiline tuberculosis mechanism efficacy
Reading File
Reading File
Here is a thorough breakdown of what BDQ (bedaquiline) does, drawn from major pharmacology textbooks:
Bedaquiline (BDQ)
Background
Bedaquiline is a diarylquinoline antibiotic, discovered in 2005 and FDA-approved in 2012 - the first TB drug with a genuinely new mechanism of action since 1971. It is classified as a Group A drug, meaning it is standard of care and should always be included in MDR-TB regimens when there are no contraindications.
Mechanism of Action
BDQ targets subunit c of the mycobacterial ATP synthase (F0 subunit). It inhibits the proton pump activity of the enzyme, cutting off ATP production - essentially starving the bacterium of energy. This mechanism is unique among TB drugs and is distinct from cell wall synthesis inhibitors, DNA gyrase inhibitors, or protein synthesis inhibitors used in older regimens.
- Active against both replicating and non-replicating (dormant) bacilli - giving it "sterilizing" activity
- MIC for M. tuberculosis: 0.03-0.12 mg/L
- Also active against M. avium complex (MAC), M. leprae, M. bovis, M. kansasii, M. abscessus, and others
Pharmacokinetics (ADME)
| Parameter | Detail |
|---|---|
| Absorption | Oral; Tmax ~5 hours; food doubles bioavailability (always take with food) |
| Distribution | Massive volume of distribution (>10,000 L); accumulates intracellularly; >99% protein-bound |
| Metabolism | CYP3A4 -> M2 metabolite (~20% activity of parent drug) |
| Elimination | Primarily fecal; half-life ~5.5 months (slow tissue redistribution) |
The extraordinarily long half-life means drug levels persist for months after stopping treatment, which has both therapeutic and drug interaction implications.
Dosing
- 400 mg once daily for 2 weeks, then
- 200 mg three times a week for 22 more weeks
- Always taken with food to maximize absorption
Clinical Use
BDQ is used in:
- MDR-TB (multidrug-resistant TB) - its primary indication; meta-analyses show improved treatment success and reduced mortality
- XDR-TB - as part of the BPaL regimen (bedaquiline + pretomanid + linezolid) for 6 months, proven highly effective
- Pre-XDR and treatment-nonresponsive MDR-TB - CDC-recommended in combination regimens
A landmark regimen from Harrison's (2025) - BDLLfxcfz (bedaquiline + delamanid + linezolid 600 mg + levofloxacin + clofazimine) - was shown non-inferior to older 9-month+ regimens for drug-resistant TB.
Resistance
- Mutations in the membrane-spanning domain of ATP synthase subunit c (D32V, A63P)
- Overexpression of efflux pumps (e.g., MmpL5/MmpS5 system) - this confers cross-resistance with clofazimine
- Resistance frequency: ~5x10^-7 to 2x10^-8 per generation
Adverse Effects & Safety
| Effect | Notes |
|---|---|
| QT prolongation | FDA black-box warning; ECG monitoring required; avoid with other QT-prolonging drugs |
| Nausea | ~26% of patients |
| Diarrhea | ~13% |
| Arthralgia / headache | Common (>25%) |
| Hepatotoxicity | Monitor liver function |
| Increased mortality signal | Observed in early trials in non-TB-specific deaths - basis of the black-box warning |
Drug Interactions
- Rifampin: reduces BDQ levels by ~50% - avoid co-administration
- CYP3A4 inducers (e.g., efavirenz): reduce BDQ exposure
- CYP3A4 inhibitors (e.g., protease inhibitors): increase BDQ and QT risk - close ECG monitoring needed
- Other QT-prolonging drugs: additive risk
Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics; Katzung's Basic & Clinical Pharmacology 16th Ed.; Harrison's Principles of Internal Medicine 22E (2025); Fishman's Pulmonary Diseases & Disorders
Should I tolerate the side effects and do test after completing first 14 days
Asking for Preferences
Finding Sources
Finding Sources
Reading File
Reading File
Important: Do Not Wait - Contact Your Doctor Now
Palpitations and dizziness are not side effects to "tolerate and push through." These are warning signs of QT prolongation - the most dangerous effect of BDQ, serious enough to carry an FDA black-box warning about associated mortality.
What the guidelines say about monitoring
According to multiple major textbooks (Murray & Nadel, Goodman & Gilman, Lippincott), the standard monitoring schedule for BDQ is:
| Time Point | What to Check |
|---|---|
| Baseline (before starting) | ECG (QTc interval) |
| Week 2 | ECG |
| Week 12 | ECG |
| Week 24 | ECG |
| Monthly | Liver function tests |
The week 2 ECG is mandatory - it is not meant to be skipped. It exists specifically to catch QT changes early in the high-dose phase (400 mg daily). If you are experiencing symptoms NOW, that ECG needs to happen TODAY or tomorrow, not at a scheduled time.
Why palpitations and dizziness are different from nausea/arthralgia
- Nausea, joint pain, headache - these are common, expected side effects that are "rarely treatment-limiting." You can generally manage them with food, hydration, and simple pain relief while staying on the drug.
- Palpitations and dizziness - these can be symptoms of a dangerously prolonged QT interval, which can lead to a fatal arrhythmia called Torsades de Pointes. This is why BDQ has a black-box warning - and this is why BDQ's QT effect is driven by its M2 metabolite, which builds up over time.
What you should do right now
- Call your TB clinic or treating doctor today and report palpitations and dizziness - do not wait for day 14
- Ask for an urgent ECG to measure your QTc interval
- Tell your doctor about any other medications you are on - fluoroquinolones, clofazimine, and many other drugs add to BDQ's QT effect
- Do not stop the drug on your own without medical guidance - stopping MDR-TB drugs incorrectly causes resistance
The joint pain and headache side of things
These are genuinely common (arthralgia >25%, headache common) and are less immediately dangerous. Your doctor may recommend:
- Taking BDQ with food
- Simple analgesics (paracetamol/acetaminophen) for joint pain and headache
- Continuing the drug unless symptoms become severe
Bottom line: The heart symptoms need medical attention now. The joint pain and headache can likely be managed, but your doctor needs to know about all of it.
Sources: Murray & Nadel's Textbook of Respiratory Medicine; Goodman & Gilman's Pharmacological Basis of Therapeutics; Lippincott Illustrated Reviews Pharmacology
Disclaimer: This is educational information only and does not replace the advice of your treating physician. MDR-TB management requires close clinical supervision.
Dr prescribed me ranitidine 150mg before meal can I take any antacid like rabeprazole or esomeprazole
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web
bedaquiline ranitidine esomeprazole rabeprazole drug interaction antacid absorption
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Here is a clear, practical answer to your question:
Ranitidine + PPI (Rabeprazole/Esomeprazole): What You Need to Know
1. Why your doctor prescribed Ranitidine
Your doctor prescribed ranitidine 150 mg before meals most likely to protect your stomach from the nausea caused by BDQ (bedaquiline). Ranitidine is an H2-blocker - it reduces stomach acid by blocking histamine H2 receptors on gastric cells.
2. Should you add a PPI on top?
Short answer: No, don't add one on your own without asking your doctor first.
Here's why:
| Issue | Explanation |
|---|---|
| Redundancy | Ranitidine and PPIs (rabeprazole, esomeprazole) both reduce stomach acid by different mechanisms. Taking both together offers little extra benefit and increases risk of side effects. |
| BDQ absorption concern | BDQ absorption is pH-dependent to some degree. Agents that strongly reduce stomach acid could potentially affect how well BDQ is absorbed. PPIs suppress acid more powerfully than ranitidine. |
| CYP2C19 interactions | Esomeprazole and rabeprazole inhibit CYP2C19. While BDQ is primarily metabolized by CYP3A4, adding CYP-active drugs unnecessarily in an already complex MDR-TB regimen is not advisable. |
| QT risk stacking | Some PPIs (particularly at high doses) have minor QT-prolonging potential. Since you are already experiencing palpitations on BDQ, adding more QT risk is not wise. |
3. What you CAN safely do for nausea/acid symptoms
- Continue ranitidine as prescribed - it is appropriate for gastric protection on BDQ
- Always take BDQ with food - this doubles its absorption AND significantly reduces nausea
- Plain antacids (like Gelusil, Digene, or similar magnesium/aluminum preparations) taken 2 hours apart from BDQ are generally acceptable for immediate relief - but check with your pharmacist first
- Avoid antacids right before or after BDQ - they can bind to drugs and reduce absorption if taken simultaneously
4. What to do
- Tell your doctor you are still having significant nausea/gastric symptoms despite ranitidine
- Do not self-add rabeprazole or esomeprazole - let your treating physician decide if a PPI is needed and which one is safest with your full regimen
- If your other TB drugs include fluoroquinolones (like levofloxacin), note that antacids with aluminum/magnesium can severely reduce their absorption - separate by at least 2 hours
The key rule: with MDR-TB, never add any new drug - even an over-the-counter one - without checking with your treating doctor first. The interactions in this regimen are complex.
Disclaimer: This is educational information only. Your treating physician knows your full regimen and medical history - always consult them before taking any additional medication.
This is a shared conversation. Sign in to Orris to start your own chat.